All Stories
Follow
Subscribe to STADA Arzneimittel AG

STADA Arzneimittel AG

Press Release: STADA Sponsors PingPongParkinson World Championship in Italy

Press Release: STADA Sponsors PingPongParkinson World Championship in Italy
  • Photo Info
  • Download

One document

Press Release

STADA Sponsors PingPongParkinson World Championship in Italy

  • STADA sponsors 6th PingPongParkinson World Championship in Lignano Sabbiadoro, Italy, from 20 to 26 October 2025
  • Partnership continues STADA’s commitment to supporting Parkinson’s community following sponsorship of 2024 PPPWC in Slovenia
  • STADA’s Global Specialty Head, Ian Henshaw: “Raising awareness and helping people diagnosed with Parkinson’s to lead as active and fulfilled a life as possible is fully in line with our purpose of Caring for People’s Health as a Trusted Partner.”

Bad Vilbel, Germany – 24 October 2025 – STADA, a leading healthcare and pharmaceuticals company specializing in Specialty pharmaceuticals, Generics and Consumer Healthcare, is further strengthening its support for the global Parkinson’s community by acting as financial sponsor of the 6th PingPongParkinson World Championship (PPPWC), taking place in Lignano Sabbiadoro, Italy, from 20 to 26 October 2025.

Following on from a similar sponsorship deal for the 5th PingPongParkinson World Championship held in Laško, Slovenia, last year, STADA is reinforcing its commitment to the Parkinson’s community in 2025.

The average player in Lignano will be 63 years old and has had Parkinson’s for eight years. Ages range from 35 to 80 years. More than 325 people will participate, drawn from 26 different countries, exceeding the previous record of 23 countries from 2023. Across singles, doubles and mixed pairs, almost 1,700 matches are scheduled during the week-long tournament, which follows previous events in Austria, Croatia, Germany, Slovenia and the USA.

“STADA is extremely proud to again serve as sponsor of the PingPongParkinson’s World Championship,” commented Ian Henshaw, STADA’s Global Specialty Head. “Raising awareness and helping people. diagnosed with Parkinson’s to lead as active and fulfilled a life as possible is fully in line with our purpose of Caring for People’s Health as a Trusted Partner.”

About STADA Arzneimittel AG

STADA Arzneimittel AG is headquartered in Bad Vilbel, Germany. The company focuses on a three-pillar strategy consisting of consumer healthcare products, generics and specialty pharma. Worldwide, STADA Arzneimittel AG sells its products in over 100 countries. In financial year 2024, STADA achieved group sales of € 4,059 million and adjusted constant-currency earnings before interest, taxes, depreciation and amortization (adj. cc EBITDA) of € 886 million. As of 31 December 2024, STADA employed 11,649 people worldwide.

About PingPongParkinson

As the first and only world championship organizers dedicated to raising awareness of the benefits of playing ping pong for the Parkinson’s community, PingPongParkinson is a not-for-profit organisation, which aims to create a global sports movement that is inclusive and supportive of people with a Parkinson diagnosis. PPP pursues the goal of freeing people with Parkinson's from their often self-imposed isolation and enabling them to lead an active and fulfilled life by participating in table tennis activities. Its mission to create a global sports movement that is inclusive and supportive of people with a Parkinson’s diagnosis. Learn more at www.pppwc.org

Additional information for journalists
STADA Arzneimittel AG - Media Relations
Stadastrasse 2-18, 61118 Bad Vilbel - Germany
Phone: +49 (0) 6101 603-165
 E-Mail:  press@stada.de
Or visit us via our website at  https://www.stada.com/media/newsroom
 Follow  @stadaGroup on LinkedIn
Additional information for capital market participants
STADA Arzneimittel AG - Investor & Creditor Relations
Stadastrasse 2-18, 61118 Bad Vilbel – Germany
Phone: +49 (0) 6101 603-4689
Fax: +49 (0) 6101 603-215
E-mail:  ir@stada.de
Or visit us via our website at  https://www.stada.com/investor-relations/
More stories: STADA Arzneimittel AG
More stories: STADA Arzneimittel AG